Explore 3 Stock Ideas & Industry Insights Download Free Report

News

REGENXBIO RGX-121 Trial Placed on FDA Clinical Hold

REGENXBIO Inc. filed a current report on August 24, 2026, disclosing that the U.S. Food and Drug Administration placed the company's Investigational New Drug application for its Phase I/II/III trial of RGX-121 on clinical hold, and that the company does not expect to resubmit …

Aakashdeep | 24 August 2026

Herc Holdings Director Erik Olsson Buys 3,085 Shares

A statement of changes in beneficial ownership filed on August 24, 2026, disclosed that Erik Olsson, a director at Herc Holdings Inc., purchased 3,085 shares of the company's common stock on August 21, 2026.

Nitish Kishor | 24 August 2026

Farmer Mac Director Disposes of 225 Shares in Gift Transaction

LaJuana S. Wilcher, a director of Federal Agricultural Mortgage Corporation, filed a statement of changes in beneficial ownership on August 24, 2026, reporting a disposition of Class C Non-Voting Common Stock on August 21, 2026.

Nitish Kishor | 24 August 2026

Blend Labs Head of Legal Reports RSU Vesting

Winnie Ling, Head of Legal and People at Blend Labs, Inc. (NYSE:BLND), filed a Form 4 on August 24, 2026, disclosing two separate RSU vesting transactions dated August 20, 2026, along with shares withheld for tax purposes.

Manish Choudhary | 24 August 2026

Blend Labs Head of Revenue Reports RSU Vesting and Share Withholding

Matthew Christopher Thomson, Head of Revenue at Blend Labs, Inc., filed a Form 4 on August 24, 2026, disclosing transactions in Class A Common Stock dated August 20, 2026, involving the vesting of restricted stock units and the withholding of shares for tax obligations.

Aakashdeep | 24 August 2026

Blend Labs Head Nima Ghamsari RSU Vesting and Tax Withholding

A Form 4 filed on August 24, 2026 disclosed that Nima Ghamsari, Director and Head of Blend at Blend Labs, Inc. (NYSE:BLND), reported restricted stock unit vestings and a share withholding transaction dated August 20, 2026.

Shwetambri Chauhan | 24 August 2026

Medtronic EVP Marinaro Reports Share Withholding for Tax

Michael Marinaro, Executive Vice President and President of MedSurg and Americas at Medtronic plc, filed a Form 4 on August 24, 2026, reporting a disposition of ordinary shares on August 20, 2026, related to restricted stock unit vesting.

Manish Choudhary | 24 August 2026

LSI Industries Director Buys 2,000 Shares in August 2026

A Form 4 filed on August 24, 2026 with the U.S. Securities and Exchange Commission discloses that Ernest W. Marshall, Jr., a director of LSI Industries Inc. (NASDAQ:LYTS), purchased a total of 2,000 common shares on August 24, 2026.

Aakashdeep | 24 August 2026

Axon Enterprise CPO & CTO Sells Shares Under 10b5-1 Plan

Jeffrey C. Kunins, Chief Product Officer and Chief Technology Officer of Axon Enterprise, Inc., filed a Form 4 on August 24, 2026, disclosing the sale of common stock on August 21, 2026, pursuant to a Rule 10b5-1 trading plan.

Vinay Lochav | 24 August 2026

Driven Brands CLO Shares Withheld for Tax on RSU Vest

Chief Legal Officer Scott L. O'Melia of Driven Brands Holdings Inc. filed a Form 4 on August 24, 2026, reporting the automatic withholding of 28,892 shares of common stock on August 21, 2026, to cover taxes owed upon the vesting of restricted stock units.

Nitish Kishor | 24 August 2026
Support

Hi! How can we help you today?

Loading…